Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.

被引：0
|
作者：
Karasu, Z [1 ]
Gurakar, A [1 ]
Jazzar, A [1 ]
Emmett, C [1 ]
Hulagu, S [1 ]
Wright, H [1 ]
机构：
[1] Baptist Med Ctr, Oklahoma Transplantat Inst, Oklahoma City, OK 73112 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1874
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 50 条
  • [41] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.
    Bernstein, DE
    Khan, R
    Jeffers, LJ
    Reddy, KR
    Schiff, ER
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [42] Treatment of relapser/nonresponder patients with chronic hepatitis C
    Dourakis, S. P.
    ANNALS OF GASTROENTEROLOGY, 2006, 19 (03): : 228 - 231
  • [43] CHANGES IN ELF SCORE DURING TREATMENT WITH PEGYLATED INTERFERON AND SILYMARIN ARE ASSOCIATED WITH PROGRESSION OF HISTOLOGICAL LIVER DISEASE IN NON-RESPONDER PATIENTS WITH CHRONIC HEPATITIS C
    Tanwar, S.
    Ellis, E.
    Parkes, J.
    Herold, C.
    Rosenberg, W.
    GUT, 2011, 60
  • [44] Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
    Kumthip K.
    Chusri P.
    Pantip C.
    Thongsawat S.
    O’Brien A.
    Maneekarn N.
    VirusDisease, 2016, 27 (1) : 55 - 62
  • [45] Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients
    Thelu, MA
    Baud, M
    Leroy, V
    Seigneurin, JM
    Zarski, JP
    JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (01) : 125 - 131
  • [46] Changes in ELF Score During Treatment With Pegylated Interferon and Silymarin Are Associated With Progression of Histological Liver Disease in Non-Responder Patients With Chronic Hepatitis C
    Tanwar, Sudeep
    Ellis, Elizabeth L.
    Parkes, Julie
    Herold, Christoph
    Rosenberg, William M.
    GASTROENTEROLOGY, 2011, 140 (05) : S979 - S979
  • [47] Immunization with the therapeutic hepatitis C virus (HCV) peptide vaccine IC41 in 66 chronic hepatitis C non-responder patients
    Manns, MP
    Berg, T
    Wedemeyer, H
    Hinrichsen, H
    Cholewinska, G
    Zeuzem, S
    Blum, H
    Buerger, V
    Klade, C
    Tauber, E
    Jelovcan, S
    Buschle, M
    Frisch, J
    HEPATOLOGY, 2004, 40 (04) : 251A - 251A
  • [48] Triple vs. double therapy of chronic hepatitis C infection in non-responder patients with high daily induction dosing of interferon alfa.
    Jaeckel, E
    Koerbel, J
    Kunka, A
    Schueler, A
    Heringlake, S
    Wedemeyer, H
    Trautwein, C
    Zankel, M
    Dreher, A
    Manns, M
    HEPATOLOGY, 1999, 30 (04) : 631A - 631A
  • [49] The combination therapy of ribavirin and pegylated interferon in non-responder, chronic HCV infection, hemodialysis patients
    Mousa, Dujanah
    Alsulaiman, Mohamad
    Alhawas, Fahad
    Alharbi, Wedad
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 197 - 197
  • [50] Interferon plus ribavirin in interferon non-responder or relapsing chronic hepatitis C patients:: End of treatment response and sustained response at third follow-up month.
    Moreno-Monteagudo, JA
    García-Buey, L
    Fernández-Bermejo, M
    Sanz, P
    Borque, MJ
    Lo Iacono, O
    García-Monzón, C
    Moreno-Otero, R
    HEPATOLOGY, 1998, 28 (04) : 476A - 476A
12345